{"id":"W6892508065","doi":"10.5281/zenodo.10818213","title":"Antibody Characterization Report for Casein kinase II subunit alpha (CSNK2A1)","year":2024,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Prion Diseases and Protein Misfolding","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Immunoprecipitation; Antibody; Alpha (finance); Casein kinase 2; Protein subunit; Kinase; Autism; Cell culture; G alpha subunit","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":{"n_in":0,"stratum":"aff_core","weight":5595.2375,"opus":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"low","reason":"Antibody characterization report benchmarking commercial antibodies against CSNK2A1 with knockout-controlled protocols; the closest rubric anchor (Western blot protocol reproducibility) puts reagent-level validation OUT, yet such standardized characterization campaigns are explicitly reagent-reproducibility infrastructure, so this sits on the boundary."},"gpt":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"The study evaluates antibody performance in laboratory assays rather than research practice itself."},"grok":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"medium","reason":"Lab reagent antibody characterization and assay performance; polysemy of validation, not study of research practice."}}}